Although both studies support lower levels of CHRM1/CHRM4 in people with schizophrenia, neither of the studies were sufficiently powered to identify the MRDS subgroup identified using postmortem CNS (Scarr et al., 2009). This evidence concerns the gene CHRM4 and schizophrenia.